SUSQUEHANNA INTERNATIONAL GROUP, LLP - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,000
-82.9%
22,900
-62.5%
0.00%
Q2 2022$35,000
+150.0%
61,000
+182.4%
0.00%
Q1 2022$14,000
-95.5%
21,600
-92.5%
0.00%
Q4 2021$308,000
+115.4%
287,768
+161.5%
0.00%
Q3 2021$143,000
+83.3%
110,045
+183.6%
0.00%
Q2 2021$78,000
-92.6%
38,800
-90.0%
0.00%
Q1 2021$1,047,000
-47.8%
387,591
-41.7%
0.00%
Q4 2020$2,004,000665,2000.00%
Other shareholders

There were no reported owners of QUALIGEN THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of QUALIGEN THERAPEUTICS INC shareholders